NPS, Forest Laboratories deal

NPSP's NPS Allelix Corp. subsidiary (Toronto, Ontario) granted FRX exclusive worldwide development and marketing rights to its ALX-0646 selective serotonin agonist to treat migraine. The product has completed Phase I testing outside the U.S.

Packard BioScience Co. (PBSC), Meriden, Conn. ...